Versor Investments LP Sells 2,356 Shares of Axon Enterprise, Inc $AXON

Versor Investments LP decreased its position in Axon Enterprise, Inc (NASDAQ:AXON) by 84.2% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 442 shares of the biotechnology company’s stock after selling 2,356 shares during the period. Versor Investments LP’s holdings in Axon Enterprise were worth $366,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. TCTC Holdings LLC grew its stake in shares of Axon Enterprise by 75.0% during the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock worth $29,000 after purchasing an additional 24 shares during the period. Banque Transatlantique SA acquired a new stake in shares of Axon Enterprise during the first quarter worth $31,000. Flaharty Asset Management LLC acquired a new stake in shares of Axon Enterprise during the first quarter worth $33,000. Hemington Wealth Management grew its stake in shares of Axon Enterprise by 70.8% during the second quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock worth $33,000 after purchasing an additional 17 shares during the period. Finally, Whipplewood Advisors LLC grew its stake in shares of Axon Enterprise by 192.9% during the second quarter. Whipplewood Advisors LLC now owns 41 shares of the biotechnology company’s stock worth $34,000 after purchasing an additional 27 shares during the period. Institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling

In related news, CAO Jennifer H. Mak sold 77 shares of the company’s stock in a transaction dated Monday, September 15th. The stock was sold at an average price of $760.00, for a total transaction of $58,520.00. Following the sale, the chief accounting officer owned 15,003 shares in the company, valued at approximately $11,402,280. This represents a 0.51% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Jeri Williams sold 100 shares of the company’s stock in a transaction dated Thursday, September 11th. The stock was sold at an average price of $752.54, for a total value of $75,254.00. Following the sale, the director owned 1,416 shares in the company, valued at $1,065,596.64. The trade was a 6.60% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 59,932 shares of company stock valued at $45,115,616. Corporate insiders own 4.40% of the company’s stock.

Wall Street Analyst Weigh In

AXON has been the subject of a number of analyst reports. Bank of America lifted their price objective on Axon Enterprise from $895.00 to $1,000.00 and gave the stock a “buy” rating in a research note on Wednesday, August 6th. Piper Sandler decreased their price objective on Axon Enterprise from $893.00 to $753.00 and set an “overweight” rating for the company in a research note on Wednesday. Cowen reaffirmed a “buy” rating on shares of Axon Enterprise in a research note on Wednesday. Zacks Research cut Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 2nd. Finally, The Goldman Sachs Group decreased their price objective on Axon Enterprise from $940.00 to $800.00 and set a “buy” rating for the company in a research note on Wednesday. Fifteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat.com, Axon Enterprise presently has an average rating of “Moderate Buy” and an average target price of $813.07.

Axon Enterprise Stock Performance

AXON stock opened at $639.53 on Thursday. The business’s 50-day moving average price is $726.40 and its two-hundred day moving average price is $735.39. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. The firm has a market cap of $50.21 billion, a PE ratio of 157.91, a P/E/G ratio of 29.49 and a beta of 1.41. Axon Enterprise, Inc has a 1-year low of $450.72 and a 1-year high of $885.91.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Tuesday, November 4th. The biotechnology company reported $1.17 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.46). The business had revenue of $710.64 million for the quarter, compared to the consensus estimate of $704.83 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The business’s revenue was up 30.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.45 earnings per share. Axon Enterprise has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, research analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.